Moderna (MRNA) stock jumped more than 6% on Wednesday after the US Food and Drug Administration agreed to review the drugmaker's first flu shot of the season, reversing course on a decision to reject ...
Moderna (MRNA) faces a lawsuit in the U.S. for allegedly infringing patent rights related to the COVID-19 shot developed by Pfizer (PFE) and BioNTech (BNTX), marking the latest such case among ...
The state Department of Health has shortened the waiting period for Rhode Islanders to receive a booster shot of the Pfizer COVID-19 vaccine. Instead of waiting six months after their first two Pfizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results